The medical research company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.02, FiscalAI reports. NeoGenomics Stock Up 2.0%NEO stock opened at $13.40 on Wednesday. Following the transaction, the director directly owned 91,422 shares of the company’s stock, valued at $1,032,154.38. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $15.14. NeoGenomics Q2 Earnings SnapshotNeoGenomics reported adjusted earnings of $0.05 per share, compared with the $0.03 FactSet consensus estimate.